Thalidomide reduced inflammatory stimulation, including the production of TNF indirectly, and interfered with the transcriptional regulation of NF‐κB in ECs directly for the simultaneous inhibition of glioma angiogenesis (Table 1). Here, NFKB1 is linked to central nervous system cancer.